News | August 22, 2023
LEO Pharma to acquire Timber Pharmaceuticals
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
The detailed terms in relation to the Rights Issue, including but not limited to the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.
The company reported lifetime high EBIDTA of Rs. 250 crores
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The business and product range of Ipca and that of Unichem complements each others business and product range
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Subscribe To Our Newsletter & Stay Updated
